Endo-microbials for improved production animal performance
The problem
Increasing consumer and regulatory pressure to end the use of antibiotics and growth promoter products in the animal protein industry.
The solution
Endo-microbials for improving livestock health and performance while concurrently replacing antibiotics.
Our engagement
Anterra participated in the Series B financing. Our co-investors include Temasek, Builders VC, Cavallo Ventures, and ADM.
Our other companies
Food marketplace helping people eat better effortlessly
Digital procurement platform for farm inputs and services
Innovative materials to extend fresh produce shelf life
Real-time data collection tools for farm machinery
Financial and data services for the fresh produce industry
Next-generation synthetic cellular controls
Drug discovery using machine learning
Genome engineering using CRSPR-Cas9
Novel flavor generation using modified brewer’s yeast
Plant-based enteral nutrition products